A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects

Cell Reports

Volumn 10, Issue 4, 2015, Pages 516-526

  Huet, Tiphaine ^a,c   Laverny, Gilles ^a   Ciesielski, Fabrice ^a,d   Molnár, Ferdinand ^a,e   Ramamoorthy, Thanuja Gali ^a,f   Belorusova, Anna Y ^a   Antony, Pierre ^a   Potier, Noelle ^b   Metzger, Daniel ^a   Moras, Dino ^a   Rochel, Natacha ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ LOUIS PASTEUR   (France)

^c CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^d Novalix   (France)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCIUM; PROTEIN DRIP205; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; PROTEIN BINDING; VITAMIN D;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; ELECTROSPRAY MASS SPECTROMETRY; FLUORESCENCE POLARIZATION; GENETICS; GENOTYPE; HEK293 CELL LINE; KNOCKOUT MOUSE; MCF 7 CELL LINE; METABOLISM; MUTATION; X RAY CRYSTALLOGRAPHY;

MUS;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; CRYSTALLOGRAPHY, X-RAY; FLUORESCENCE POLARIZATION; GENOTYPE; HEK293 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, KNOCKOUT; MUTATION; PROTEIN BINDING; RECEPTORS, CALCITRIOL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VITAMIN D;

EID: 84922826171     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.045     Document Type: Article

References (43)

1. Adorini L., Amuchastegui S., Corsiero E., Laverny G., Le Meur T., Penna G. Vitamin D receptor agonists as anti-inflammatory agents. Expert Rev. Clin. Immunol. 2007, 3:477-489.
2. Bouillon R., Suda T. Vitamin D: calcium and bone homeostasis during evolution. Bonekey Rep. 2014, 3:480.
3. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008, 29:726-776.
4. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol. Endocrinol. 2005, 19:1418-1428.
5. Champy M.F., Selloum M., Piard L., Zeitler V., Caradec C., Chambon P., Auwerx J. Mouse functional genomics requires standardization of mouse handling and housing conditions. Mamm. Genome 2004, 15:768-783.
6. Chen C.H., Sakai Y., Demay M.B. Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 2001, 142:5386-5389.
7. Ciesielski F., Rochel N., Moras D. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation. J.Steroid Biochem. Mol. Biol. 2007, 103:235-242.
8. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
9. Dardenne O., Prudhomme J., Hacking S.A., Glorieux F.H., St-Arnaud R. Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J.Bone Miner. Res. 2003, 18:637-643.
10. Dembélé D., Kastner P. Fold change rank ordering statistics: a new method for detecting differentially expressed genes. BMC Bioinformatics 2014, 15:14.
11. Dupé V., Davenne M., Brocard J., Dollé P., Mark M., Dierich A., Chambon P., Rijli F.M. Invivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). Development 1997, 124:399-410.
12. Duteil D., Chambon C., Ali F., Malivindi R., Zoll J., Kato S., Geny B., Chambon P., Metzger D. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 2010, 12:496-508.
13. Eelen G., Verlinden L., Rochel N., Claessens F., De Clercq P., Vandewalle M., Tocchini-Valentini G., Moras D., Bouillon R., Verstuyf A. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol. Pharmacol. 2005, 67:1566-1573.
14. Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., Möller G., Adamski J., Balling R. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 2002, 16:1524-1537.
15. Feldman D., Malloy P.J. Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep. 2014, 3:510.
16. Huet T., Maehr H., Lee H.J., Uskokovic M.R., Suh N., Moras D., Rochel N. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. Medchemcomm 2011, 2:424-429.
17. Laverny G., Penna G., Uskokovic M., Marczak S., Maehr H., Jankowski P., Ceailles C., Vouros P., Smith B., Robinson M., et al. Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3. J.Med. Chem. 2009, 52:2204-2213.
18. Laverny G., Penna G., Vetrano S., Correale C., Nebuloni M., Danese S., Adorini L. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol. Lett. 2010, 131:49-58.
19. Lee H.J., Paul S., Atalla N., Thomas P.E., Lin X., Yang I., Buckley B., Lu G., Zheng X., Lou Y.R., et al. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity. Cancer Prev. Res. (Phila.) 2008, 1:476-484.
20. Lee S.M., Goellner J.J., O'Brien C.A., Pike J.W. A humanized mouse model of hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. Endocrinology 2014, 155:4137-4148.
21. Leyssens C., Verlinden L., Verstuyf A. The future of vitamin D analogs. Front Physiol 2014, 5:122.
22. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., Demay M.B. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
23. Lieben L., Carmeliet G. The delicate balance between vitamin D, calcium and bone homeostasis: lessons learned from intestinal- and osteocyte-specific VDR null mice. J.Steroid Biochem. Mol. Biol. 2013, 136:102-106.
24. Lieben L., Carmeliet G. Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis. Bone 2013, 54:237-243.
25. Lieben L., Carmeliet G., Masuyama R. Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:561-572.
26. Lieben L., Masuyama R., Torrekens S., Van Looveren R., Schrooten J., Baatsen P., Lafage-Proust M.H., Dresselaers T., Feng J.Q., Bonewald L.F., et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J.Clin. Invest. 2012, 122:1803-1815.
27. Lips P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006, 92:4-8.
28. Lou Y.R., Molnár F., Peräkylä M., Qiao S., Kalueff A.V., St-Arnaud R., Carlberg C., Tuohimaa P. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J.Steroid Biochem. Mol. Biol. 2010, 118:162-170.
29. Maehr H., Uskokovic M., Adorini L., Penna G., Mariani R., Panina P., Passini N., Bono E., Perego S., Biffi M., et al. Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition. J.Steroid Biochem. Mol. Biol. 2007, 103:277-281.
30. Malloy P.J., Feldman D. The role of vitamin D receptor mutations in the development of alopecia. Mol. Cell. Endocrinol. 2011, 347:90-96.
31. Malloy P.J., Tasic V., Taha D., Tütüncüler F., Ying G.S., Yin L.K., Wang J., Feldman D. Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol. Genet. Metab. 2014, 111:33-40.
32. Marx S.J., Bliziotes M.M., Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol. (Oxf.) 1986, 25:373-381.
33. Meyer M.B., Zella L.A., Nerenz R.D., Pike J.W. Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine invivo. J.Biol. Chem. 2007, 282:22344-22352.
34. Meyer M.B., Goetsch P.D., Pike J.W. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. J.Biol. Chem. 2010, 285:15599-15610.
35. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:7498-7503.
36. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 2005, 6:542-554.
37. Picardi M., Muretto P., De Rosa G., Selleri C., De Renzo A., Persico M., Rotoli B. Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. Haematologica 2002, 87:652-657.
38. Rochel N., Moras D. Ligand binding domain of vitamin D receptors. Curr. Top. Med. Chem. 2006, 6:1229-1241.
39. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 2000, 5:173-179.
40. Skorija K., Cox M., Sisk J.M., Dowd D.R., MacDonald P.N., Thompson C.C., Demay M.B. Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Mol. Endocrinol. 2005, 19:855-862.
41. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., Li M., Chambon P. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
42. Xue Y., Fleet J.C. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology 2009, 136:1317-1327. e1-e2.
43. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.